As this wave of GLP-1 marketing hits shelves, its important to stay mindful of what these labels really mean - and what they dont
Since it is still experimental and has not yet been approved of veterinary use, care must be taken
GLOW adds a cosmetic/collagen ingredient
That question sits at the junction of hope, marketing, and real clinical science
The main findings highlight that high-dose EPA substantially reduced migraine frequency and severity, improved psychological symptoms, and enhanced the quality of life for episodic migraine patients, suggesting its potential as an effective prophylactic, particularly for female patients
Journal: The Lancet Year: 1982 Link: Access the study on ScienceDirect Summary: This study demonstrated that Sermorelin (GHRH 129) effectively stimulates growth hormone secretion in children with growth hormone deficiency, leading to improved growth rates